
Common name
[(1S,3S,7R,8aR)-3-hydroxy-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] formate
IUPAC name
[(1S,3S,7R,8aR)-3-hydroxy-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] formate
SMILES
O(C=O)C1C2CC(C=CC2=CC(C1)O)C
Common name
[(1S,3S,7R,8aR)-3-hydroxy-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] formate
IUPAC name
[(1S,3S,7R,8aR)-3-hydroxy-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] formate
SMILES
O(C=O)C1C2CC(C=CC2=CC(C1)O)C
INCHI
InChI=1S/C12H16O3/c1-8-2-3-9-5-10(14)6-12(15-7-13)11(9)4-8/h2-3,5,7-8,10-12,14H,4,6H2,1H3/t8-,10+,11+,12-/m0/s1
FORMULA
C12H16O3

Common name
[(1S,3S,7R,8aR)-3-hydroxy-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] formate
IUPAC name
[(1S,3S,7R,8aR)-3-hydroxy-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] formate
Molecular weight
208.254
clogP
0.992
clogS
-0.525
Frequency
0.0003
HBond Acceptor
3
HBond Donor
1
Total PolarSurface Area
46.53
Number of Rings
2
Rotatable Bond
2
Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
---|---|---|---|---|
FDBD00064 | Pravastatin |
![]() |
Anticholesteremic Agents; Hydroxymethylglutaryl-CoA Reductase Inhibitors; HMG CoA Reductase Inhibitors; Lipid Modifying Agents, Plain; Lipid Modifying Agents; Cardiovascular System; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C8 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; Combined Inhibitors of CYP3A4 and P-glycoprotein; | For the treatment of hypercholesterolemia and to reduce the risk of cardiovascular disease. |
FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
---|---|---|---|---|---|
1xdg_ligand_2_39.mol2 | 1xdg | 0.835821 | -7.51 | [C@H]1([C@@H]2C(=C[C@@H](C[C@@H]2OC=O)C)C=C[C@@H]1C)CC | 17 |
1xdg_ligand_1_7.mol2 | 1xdg | 0.835821 | -7.50 | [C@H]1([C@@H]2C(=C[C@@H](C[C@@H]2OC=O)C)C=C[C@@H]1C)C | 16 |
1cqp_ligand_2_0.mol2 | 1cqp | 0.835821 | -7.49 | CC[C@H]1[C@H](C=CC2=C[C@@H](C[C@@H]([C@H]12)OC=O)C)C | 17 |
1cqp_ligand_1_0.mol2 | 1cqp | 0.835821 | -7.48 | C[C@H]1[C@H](C=CC2=C[C@@H](C[C@@H]([C@H]12)OC=O)C)C | 16 |
1xdg_ligand_frag_8.mol2 | 1xdg | 0.835821 | -7.34 | C1[C@@H]2C(=C[C@@H](C[C@@H]2OC=O)C)C=C[C@@H]1C | 15 |
1cqp_ligand_frag_0.mol2 | 1cqp | 0.835821 | -7.32 | [C@@H]1(C[C@H](C=C2C=C[C@@H](C[C@@H]12)C)C)OC=O | 15 |
1xdd_ligand_2_8.mol2 | 1xdd | 0.756757 | -8.16 | C[C@@H]1[C@H]2[C@H](C[C@H](C=C2C=C[C@@H]1C)C)OC(=O)CC | 18 |
1xdd_ligand_1_1.mol2 | 1xdd | 0.756757 | -7.98 | [C@@H]1(C[C@H](C=C2[C@H]1C[C@H](C=C2)C)C)OC(=O)CC | 17 |
1xdg_ligand_2_42.mol2 | 1xdg | 0.756757 | -7.96 | [C@H]1([C@@H]2C(=C[C@@H](C[C@@H]2OC(=O)CC)C)C=C[C@@H]1C)C | 18 |
1cqp_ligand_2_2.mol2 | 1cqp | 0.756757 | -7.94 | C(C)C(=O)O[C@H]1C[C@H](C=C2C=C[C@@H]([C@H](C)[C@@H]12)C)C | 18 |